Progyny-Aktie: “Rückgang des EBITDA-Wachstums rightfertigt niedrigeres Bewertungsmultiple”

On Thursday, JMP Securities has a stake in the development of products, on the NASDAQ:PGNY, which is aware of companies for fruit bargeitsleistungen. The company that executes the action “Market Outperform” on “Market Perform” can issue more ideas about the Wachstum-sausviechten of the Unternehmens.

The new development, which comes from the redevelopment of the Australian confrontation, will take the watch in 2024. Analysts at JMP Securities know that the Schwan-kungen are in the typical American interest rate challenge, the risk that reflects the American legislation and regulations and the latest information on the Wachstum of Progyny has again behind it.

Consider JMP Securities’ reservations about the financial outlook for the future. The company’s 2025 revenue from $1.30 million to $1.17 million was a 5% shortfall in the annual review. It is possible that the EBITDA (Ergebnis vos Zinsen, Steuern, Abschreibungen en Amortisatieen) will be reduced by 10% to $203 million in 2025.

The new financing of the Progyny economy mirrors a German view of the annual EBITDA waiting figures of the unternehmens wider, that there is an Anstieg of 87% in the year 2022 on a zero waiting period until 2025 sunk. The analyst looks at the insight that the strong analyses of the waiting states are a number of new assessments for the bailiff of Progyny.

Based on those forecasts and JMP Securities’ active trading multiples, an 8x EBITDA 2025 is fair world, with the Progyny-aktien price after the interest on the Mittwoch . This new Bewertung reflects the Firm’s time and the Company’s financial Leistung in the coming years more broadly.

In other cases, Progyny Inc. is going to be one of the best companies available on 01.01.2025, which uses 12% to 13% of the US power. If it is a different version, then this Entwicklung is no more negative than the financial situation on 31.12.2024 that ends with the financing.

Progyny erwartet für 2025 een Anstieg seiner Gesamtmitgliederzahl en zeigte sich züversichtlich hinsichtlich seines anhaltenden Wachstums, seiner Rentabilität and seines Cashflows. The second rate cut in the 2024 quarter of US$304.1 million was a 9% antieg earned in the past.

Firstly, move on to the expected long-term cost forecast for reproductive technology assistance and minor personal adjustments with your acquaintance.

KeyBanc Capital Markets analysts have chosen a “Sector Weight” rating for their products when creating a summary of our companies’ most recent financial financings.

Progyny übernahm kürzlich found a platform for Facility-Benefits in Berlin, April, and entered into a partnership with Meritene Health one, which is a greater challenge worldwide. You can buy a new product program in the future of 100 million dollars and plant the new production in 2025.

InvestingPro Insights

If you are concerned with the young reabstufung of progyny by JMP Securities, this is a good knowledge of InvestingPro, who provide investors with more information about the financial well-being and market position of their alternative darling stocks. When InvestingPro buys the management of Progyny active stocks back, it could be seen as a sign of trust in the company value. Additionally, Progyny falls over more cash than debt in its balance sheet, was a bullet for operating notices and potential investment opportunities.

With a cautious analysis of Progyny’s market capitalization of 2.21 billion US dollars, and the world trading with a profit margin of 37.87, was a premium rating on the broader market mirror. The company’s net profit margin in the last few months to the second quarter of 2024 was 18.33%, a solid sales increase was achieved. As earnings had increased on a high return on EBITDA of 58.29%, it was a positive result for profitability.

Investors who make such an analysis will find similar InvestingPro tips for their offspring, who attempt in the business market of their companies, their net procurements and the simple simplification of the Free-Cashflow-Rendite dealing. There are 14 other tips for InvestingPro that offer one of the following possibilities to explore financial prospects and markets.

These well-known investors combined with the broad market analysis can help finance investments in Progyny projects. For a detailed overview of Progyny’s funding and analyst forecasts, visit https://de.investing.com/pro/PGNY.

This description can be performed by the intelligent intelligence. Weitere Informationen entnehmen Sie bitte unseren Nutzungsbedingungen.